Neurodegenerative diseases such as Alzheimer's disease and chronic traumatic encephalopathy (CTE) can be easily identified using artificial intelligence (AI), reports a new study. The findings of the study are published in the Nature medical journal Laboratory Investigation.
A team of researchers has developed an artificial intelligence platform to detect a range of neurodegenerative disease in human brain tissue samples, including Alzheimer's disease and chronic traumatic encephalopathy, according to a study conducted at the Icahn School of Medicine at Mount Sinai. Their discovery will help scientists develop targeted biomarkers and therapeutics, resulting in a more accurate diagnosis of complex brain diseases that improve patient outcomes.
Alzheimers Disease
Alzheimer''s disease is a progressive neurodegenerative disease affecting memory and thinking and making the person increasingly dependent on others.
Advertisement
‘Artificial intelligence (AI) platform can help identify a range of neurodegenerative diseases such as Alzheimer's disease and chronic traumatic encephalopathy (CTE).’
Read More..
Tweet it Now
Read More..
The buildup of abnormal tau proteins in the brain in neurofibrillary tangles is a feature of Alzheimer's disease, but it also accumulates in other neurodegenerative diseases, such as chronic traumatic encephalopathy and additional age-related conditions. Accurate diagnosis of neurodegenerative diseases is challenging and requires a highly-trained specialist.
A team of researchers at the Center for Computational and Systems Pathology at Mount Sinai developed and used the Precise Informatics Platform to apply powerful machine learning approaches to digitized microscopic slides prepared using tissue samples from patients with a spectrum of neurodegenerative diseases. Applying deep learning, these images were used to create a convolutional neural network capable of identifying neurofibrillary tangles with a high degree of accuracy directly from digitized images.
![Artificial intelligence in Healthcare]( "Artificial intelligence in Healthcare")
Artificial intelligence (AI) in healthcare is the discipline using data intensive computer based solutions to improve patient care and outcome.
"Utilizing artificial intelligence has great potential to improve our ability to detect and quantify neurodegenerative diseases, representing a major advance over existing labor-intensive and poorly reproducible approaches," said lead investigator John Crary, MD, Ph.D., Professor of Pathology and Neuroscience at the Icahn School of Medicine at Mount Sinai. "Ultimately, this project will lead to more efficient and accurate diagnosis of neurodegenerative diseases."
This is the first framework available for evaluating deep learning algorithms using large-scale image data in neuropathology. The Precise Informatics Platform allows for data management, visual exploration, object outlining, multi-user review, and evaluation of deep learning algorithm results. The research team at the Center for Computational and Systems Pathology at Mount Sinai have used use advanced computer science and mathematical techniques coupled with cutting-edge microscope technology, computer vision, and artificial intelligence to more accurately classify a broad array of diseases.
"Mount Sinai is the largest academic pathology department in the country and processes more than 80 million tests a year, which offers researchers access to a broad set of data that can be used to improve testing and diagnostics, ultimately leading to better diagnosis and patient outcomes," said author Carlos Cordon-Cardo, MD, PhD, Chair of the Department of Pathology at the Mount Sinai Health System and Professor of Pathology, Genetics and Genomic Sciences, and Oncological Sciences at the Icahn School of Medicine.
Source: Eurekalert
Artificial intelligence in Healthcare
Artificial intelligence (AI) in healthcare is the discipline using data intensive computer based solutions to improve patient care and outcome.
Advertisement
"Utilizing artificial intelligence has great potential to improve our ability to detect and quantify neurodegenerative diseases, representing a major advance over existing labor-intensive and poorly reproducible approaches," said lead investigator John Crary, MD, Ph.D., Professor of Pathology and Neuroscience at the Icahn School of Medicine at Mount Sinai. "Ultimately, this project will lead to more efficient and accurate diagnosis of neurodegenerative diseases."
This is the first framework available for evaluating deep learning algorithms using large-scale image data in neuropathology. The Precise Informatics Platform allows for data management, visual exploration, object outlining, multi-user review, and evaluation of deep learning algorithm results. The research team at the Center for Computational and Systems Pathology at Mount Sinai have used use advanced computer science and mathematical techniques coupled with cutting-edge microscope technology, computer vision, and artificial intelligence to more accurately classify a broad array of diseases.
"Mount Sinai is the largest academic pathology department in the country and processes more than 80 million tests a year, which offers researchers access to a broad set of data that can be used to improve testing and diagnostics, ultimately leading to better diagnosis and patient outcomes," said author Carlos Cordon-Cardo, MD, PhD, Chair of the Department of Pathology at the Mount Sinai Health System and Professor of Pathology, Genetics and Genomic Sciences, and Oncological Sciences at the Icahn School of Medicine.
Source: Eurekalert
Artificial Intelligence Can Help Detect Early Signs of Alzheimer's
Artificial intelligence (AI) could offer a new promising way to identify early signs of Alzheimer's, reveals a new study.
Advertisement
 Memory, Mood, Behavior Could Be Affected In Athletes With Chronic Traumatic EncephalopathyChronic traumatic encephalopathy (CTE), may affect people in two major ways: initially affecting behavior or mood or initially affecting memory and thinking abilities, reveals new research. | Advertisement
|
Advertisement
Recommended Readings
Latest Research News
A latest research suggests that the quality of a person's post-work recovery in the evening can impact their mood when they resume work the next day.
Researchers are working on new strategies and solutions for sleep apnea to ward off a range of health risks including cognitive decline.
The scientists discovered that when the stem cells in the hair follicle are made softer, they have a higher chance of growing hair.
A combinatorial therapy provided promising beneficial results among people with ischemic stroke.
In Parkinson's disease patients voice disorders are quite common. A new combination therapy had greater effects on the voice.